Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 110
Filtrer
1.
Transl Med UniSa ; 19: 42-48, 2019.
Article de Anglais | MEDLINE | ID: mdl-31360666

RÉSUMÉ

We developed and tested an innovative physical training method in older adults that embeds the gym program into everyday life in the most conservative way possible. Physical training was included in the activities of local parishes where older women from Southern Italy spend most of their free time and was delivered by trained physical therapists with the support of an ICT tool known as CoCo. 113 older women (aged 72.0 [69.0-75.0] years) noncompliant to conventional exercise programs participated to the study. 57 of them underwent the final anthropometric assessment and 50 the final physical tests. In study completers handgrip strength and physical performance evaluated with the chair-stand, the two minutes step and the chair-sit and -reach tests significantly improved. Quality of life as evaluated with the EuroQol-5dimension (EQ-5D) questionnaire improved as well. In conclusion, a training program designed to minimally impact on life habits of older people is effective in improving fitness in patients noncompliant to other to physical exercise programs.

2.
Transl Med UniSa ; 19: 116-123, 2019.
Article de Anglais | MEDLINE | ID: mdl-31360676

RÉSUMÉ

The demographic projections on the European population predict that people aged over 60 will increase by about two million/year in the next decades. Since 2012, the Campania Reference Site of the European Innovation Partnership on Active and Healthy Ageing supports the innovation of the Regional Health System, to face up demographic changes and sustainability. Campania Reference Site provides the opportunity to connect loco-regional stakeholders in social and health care services (universities, healthcare providers, social services, local communities and municipalities), with international organizations, in order to adopt and scale up innovative solutions and approaches. This paper describes the building process of Campania Reference Site and the main results achieved, that have been allowing it to become a hub for open innovation in the field of active and healthy aging at regional, national and international level.

3.
Eur Surg Res ; 50(3-4): 262-72, 2013.
Article de Anglais | MEDLINE | ID: mdl-23751813

RÉSUMÉ

BACKGROUND: A wide variety of meshes are available for surgical treatment of abdominal wall defects. These meshes are constructed with different materials with different biological properties. METHODS: A prospective database was instituted (January 2009-December 2010) to register biological prostheses (BPs) implanted in Italy. RESULTS: A total of 193 cases were registered. The mean age of the patients was 53.1 years (SD ±7.4). The ratio of males to females was 1.3 to 1. The mean body mass index was 28.2 (SD ±4.1). The breakdown of American Society of Anesthesiologists (ASA) scores was as follows: ASA I, 35.7%; ASA II, 27.5%; ASA III, 31.6%, and ASA IV, 5.2%. For ventral-incisional hernias, the mean duration of surgery was 101.1 min (SD ±25.3), while for inguinal-femoral hernias it was 49.2 min (SD ±19.1). The rate of urgent procedures was 36.7%. The surgical field was clean in 57.4% of cases, clean-contaminated in 21.3%, contaminated in 12.3% and dirty in 9%. Techniques used for inguinal-femoral hernias were as follows: Lichtenstein in 66.7%, plug and mesh in 3.8%, transabdominal-preperitoneal in 25.7% and intraperitoneal onlay mesh in 3.8%. The following prostheses were used: swine intestinal submucosa in 54.9%, porcine dermal collagen in 39.9% and bovine pericardium in 5.2%. In 45.1% of cases the prostheses were cross-linked. Techniques used for ventral-incisional hernias were as follows: onlay in 3.6%, inlay in 5.5%, sublay in 62.7% and underlay via laparoscopy in 28.2%. The mean overlap was 4.1 cm (SD ±1.2). No intestinal anastomosis was necessary in 65.3% of cases; however, small/large bowel resection and anastomoses were necessary in 22.3 and 12.4% of cases, respectively. Intraoperative blood transfusion was necessary in 10.4% of procedures. The skin was completely closed in 84% of procedures. At the 1-month follow-up, there were no complications in 54.4% of cases. Among the cases with complications, 10 patients (5.8%) experienced recurrence, and the postoperative readmission rate was 12.9%. The average visual analog scale (VAS) score for pain was 2.9 (SD ±1.2) at rest. At the 1-year follow-up, there were no complications in 96.4% of cases. Two patients experienced recurrence, and the postoperative readmission rate was 3.6%. The average VAS score for pain was 1.8 (SD ±0.8) at rest. CONCLUSIONS: This register shows that BPs are highly versatile and can be used in either open or laparoscopic surgery in all kinds of patients and in contaminated surgical fields. However, due to the very good outcomes of synthetic meshes and the high costs of BPs, the latter should only be used in selected cases.


Sujet(s)
Bioprothèse , Herniorraphie/méthodes , Enregistrements , Animaux , Bioprothèse/effets indésirables , Bovins , Bases de données factuelles , Femelle , Hernie abdominale/chirurgie , Herniorraphie/effets indésirables , Humains , Italie , Mâle , Adulte d'âge moyen , Études prospectives , Filet chirurgical/effets indésirables , Suidae
4.
Complement Ther Med ; 19(4): 228-37, 2011 Aug.
Article de Anglais | MEDLINE | ID: mdl-21827937

RÉSUMÉ

It is commonly accepted that nutrition is one of the possible environmental factors involved in the pathogenesis of multiple sclerosis (MS), but its role as complementary MS treatment is unclear and largely disregarded. At present, MS therapy is not associated to a particular diet, probably due to lack of information on the effects of nutrition on the disease. To overcome the distrust of the usefulness of dietary control in MS and to encourage nutritional interventions in the course of the disease, it is necessary to assess the nature and the role of bioactive dietary molecules and their targets, and establish how a dietary control can influence cell metabolism and improve the wellness of MS patients. The aim of this review is to provide a rationale for a nutritional intervention in MS by evaluating at the molecular level the effects of dietary molecules on the inflammatory and autoimmune processes involved in the disease. Present data reveal that healthy dietary molecules have a pleiotropic role and are able to change cell metabolism from anabolism to catabolism and down-regulate inflammation by interacting with enzymes, nuclear receptors and transcriptional factors. The control of gut dysbiosis and the combination of hypo-caloric, low-fat diets with specific vitamins, oligoelements and dietary integrators, including fish oil and polyphenols, may slow-down the progression of the disease and ameliorate the wellness of MS patients.


Sujet(s)
Inflammation/métabolisme , Sclérose en plaques/diétothérapie , Évolution de la maladie , Enzymes/métabolisme , Huiles de poisson/pharmacologie , Huiles de poisson/usage thérapeutique , Humains , Intestins/microbiologie , Sclérose en plaques/métabolisme , Polyphénols/pharmacologie , Polyphénols/usage thérapeutique , Prébiotiques , Récepteurs cytoplasmiques et nucléaires/métabolisme , Facteurs de transcription/métabolisme
5.
J Neurovirol ; 15(4): 348-50, 2009 Jul.
Article de Anglais | MEDLINE | ID: mdl-19579072

RÉSUMÉ

Severe adverse reaction to yellow fever (YF) vaccine includes the yellow fever vaccine-associated neurotropic disease. This terminology includes postvaccinal encephalitis, acute disseminated encephalomyelitis, and Guillain-Barré syndrome. The objective of this communication is to report a patient who received a YF vaccine in Argentina and subsequently developed longitudinal myelitis with a symptom that had previously gone unreported in the literature. A 56-year-old man began with progressive paraparesia, urinary retention, and constipation 48 h previous to admission. The patient received YF vaccine 45 days prior to the onset of the symptoms. There was no history of other immunization or relevant condition. MR of the spine showed longitudinal intramedullary hyperintense signal (D5-12) without gadolinium enhancement. A high concentration of YFV-specific IgM vaccine antibody was found in the cerebrospinal fluid (CSF). Serological tests for other flavivirus were negative. A diagnosis of longitudinal myelitis without encephalitis associated with YF vaccine was performed and symptoms improved 5 days later. This is the first report dealing with longitudinal myelitis as a serious adverse event associated with YF vaccination in which confirmation of the presence of antibodies in CSF was found. To date, it is also the first report with serological confirmation in Argentina and in South America. We consider that the present investigation will raise awareness in the region in the reporting of adverse events related to YF vaccine and improve our knowledge of adverse reactions to the vaccine.


Sujet(s)
Anticorps antiviraux/liquide cérébrospinal , Myélite transverse/diagnostic , Myélite transverse/étiologie , Vaccination/effets indésirables , Vaccin antiamaril/effets indésirables , Argentine , Humains , Immunoglobuline M , Mâle , Adulte d'âge moyen , Myélite transverse/liquide cérébrospinal , Fièvre jaune/immunologie , Fièvre jaune/prévention et contrôle , Virus de la fièvre jaune/immunologie
6.
Mult Scler ; 15(5): 555-62, 2009 May.
Article de Anglais | MEDLINE | ID: mdl-19299437

RÉSUMÉ

BACKGROUND: The influence of pregnancy on Multiple Sclerosis (MS) has been extensively studied but such influence on Latin American women with MS has not been characterized. Our objective was to describe the course of pregnancy and birth outcome in Argentinean MS patients and the evolution of MS during pregnancy and after delivery. METHOD: We used a retrospective design in eight MS centers in Argentina and administered a survey to women with definite MS (Mc Donald) with pregnancies during or after MS onset. We contacted 355 women of which 81 met inclusion criteria. We recorded 141 pregnancies. RESULTS: Involuntary abortion was observed in 16% of pregnancies (95% CI = 10-23). Thirty five women received immunomodulatory therapy (IMT) before 42 pregnancies. Twenty three (55%) out of 42 pregnancies were exposed to IMT. The mean time of IMT discontinuation before conception in 19 (45.2%) pregnancies without exposure, was 104 days (95% CI = 61.0-147.0). There were 103 deliveries: 79% full term. Birth defects were detected in 19% of pregnancies exposed to IMT (95% CI = 4-46) and in 2% of non-exposed (95% CI = 0.3-8.0). The mean relapse rate was: pre-pregnancy year: 0.22 (95% CI = 0.12-0.32); pregnancy: 0.31 in 1st (95% CI = 0.10-0.52), 0.19 (95% CI = 0.03-0.36) in 2nd, and 0.04 in 3rd trimester (95% CI = -0.04-0.12); 1st trimester post delivery: 0.82 (95% CI = 0.42-1.22). CONCLUSION: We observed a higher rate of birth defects among infants exposed to immunomodulators in utero than those not exposed. The reduction in MS relapses during 2nd and 3rd trimester of pregnancy and its increase during postpartum is consistent with previous reports.


Sujet(s)
Malformations/épidémiologie , Accouchement (procédure)/statistiques et données numériques , Sclérose en plaques/épidémiologie , Complications de la grossesse/épidémiologie , Issue de la grossesse/épidémiologie , Adulte , Sujet âgé , Argentine/épidémiologie , Allaitement naturel/statistiques et données numériques , Collecte de données , Femelle , Humains , Immunosuppresseurs/usage thérapeutique , Nouveau-né , Adulte d'âge moyen , Sclérose en plaques/traitement médicamenteux , Période du postpartum , Grossesse , Deuxième trimestre de grossesse , Troisième trimestre de grossesse , Études rétrospectives , Facteurs de risque , Jeune adulte
7.
Dev Neurosci ; 30(4): 224-30, 2008.
Article de Anglais | MEDLINE | ID: mdl-17962714

RÉSUMÉ

Studies dealing with the outcomes of developmental carbon monoxide (CO) exposure on myelination in rat offspring are reviewed. Prenatal CO exposure from gestational day 0 to gestational day 20 impairs myelin deposition around peripheral axons resulting in a significant hypomyelination in juvenile and adult rats. Myelin protein patterns analyzed by SDS-polyacrylamide gel electrophoresis and lipid patterns analyzed by the HPTLC method are not altered in both peripheral and central nervous systems of CO-exposed offspring. Interestingly, when sphingomyelin is extracted and purified, the derivatization by OPA reagent and analysis by reversed-phase HPLC reveal a significant increase in sphingosine levels in peripheral nervous system but not in central nervous system of CO-exposed rats. The above morphological and biochemical alterations are not accompanied by motor disabilities.


Sujet(s)
Neuropathies périphériques/épidémiologie , Complications de la grossesse/épidémiologie , Fumer/épidémiologie , Animaux , Femelle , Humains , Grossesse , Facteurs de risque
8.
Langmuir ; 23(16): 8491-6, 2007 Jul 31.
Article de Anglais | MEDLINE | ID: mdl-17616158

RÉSUMÉ

Multilayers consisting of negatively charged phospholipid DMPA and myelin basic protein (MBP) were assembled by Langmuir-Blodgett deposition of floating Langmuir monolayers from the air/water interface to solid substrates. Protein/lipid samples were obtained by binding MBP from the aqueous subphase to the phospholipid monolayers before deposition. The vertical organization of these model membranes (i.e., with organization perpendicular to the substrate surface) was investigated in detail by neutron reflectivity measurements, and the internal distribution of water molecules was determined from the change of contrast after in-situ H2O/D2O exchange. The multilayers were well ordered, with repeating lipid bilayers as fundamental structural unit. MBP was inserted in between adjacent lipid headgroups, such as in the natural myelin membrane. Water molecules in the multilayers were present mainly in the lipid headgroup and protein slab. On exposition of the pure lipid multilayers to a dry atmosphere, a reduction of the bilayer spacing was determined, whereas the global lamellar order was not affected. In contrast, drying of the protein/lipid multilayers induced degradation of the laminar order. The data demonstrate that ordered Langmuir-Blodgett multilayers are versatile model systems for studying how competing interactions between lipid, protein, water, and ions affect the global organization of such multilamellar lipid/protein assemblies. Here, the water molecules were found to be a necessary mediator to maintain the laminar order in a multilayer from DMPA and myelin basic protein.


Sujet(s)
Membrane artificielle , Modèles chimiques , Protéine basique de la myéline/composition chimique , Neutrons , Phospholipides/composition chimique , Eau/composition chimique , Animaux , Bovins , Oxydoréduction , Transition de phase
9.
Biophys J ; 93(6): 1999-2010, 2007 Sep 15.
Article de Anglais | MEDLINE | ID: mdl-17513373

RÉSUMÉ

Myelin basic protein (MBP) is a major protein of the myelin membrane in the central nervous system. It is believed to play a relevant role in the structure and function of the myelin sheath and is a candidate autoantigen in demyelinating processes such as multiple sclerosis. MBP has many features typical of soluble proteins but is capable of strongly interacting with lipids, probably via a conformation change. Its structure in the lipid membrane as well as the details of its interaction with the lipid membrane are still to be resolved. In this article we study the interaction of MBP with Langmuir films of anionic and neutral phospholipids, used as experimental models of the lipid membrane. By analyzing the equilibrium surface pressure/area isotherms of these films, we measured the protein partition coefficient between the aqueous solution and the lipid membrane, the mixing ratio between protein and lipid, and the area of the protein molecules inserted in the lipid film. The penetration depth of MBP in the lipid monolayer was evaluated by x-ray reflectivity measurements. The mixing ratio and the MBP molecular area decrease as the surface pressure increases, and at high surface pressure the protein is preferentially located at the lipid/water interface for both anionic and neutral lipids. The morphology of MBP adsorbed on lipid films was studied by atomic force microscopy. MBP forms bean-like structures and induces a lateral compaction of the lipid surface. Scattered MBP particles have also been observed. These particles, which are 2.35-nm high, 4.7-nm wide, and 13.3-nm long, could be formed by protein-lipid complexes. On the basis of their size, they could also be either single MBP molecules or pairs of c-shaped interpenetrating molecules.


Sujet(s)
Lipides membranaires/composition chimique , Protéine basique de la myéline/composition chimique , Animaux , Phénomènes biophysiques , Biophysique , Bovins , Dimyristoylphosphatidylcholine/composition chimique , Membrane artificielle , Microscopie à force atomique , Modèles moléculaires , Structure moléculaire , Phosphatidylsérine/composition chimique , Thermodynamique
10.
J Biotechnol ; 120(2): 220-7, 2005 Nov 04.
Article de Anglais | MEDLINE | ID: mdl-16083984

RÉSUMÉ

Miniature (20 g) Cheddar-type cheeses were manufactured using enzymes extracted from the crustacean Munida or chymosin as coagulant. Cheeses were ripened at 8 degrees C and samples were collected for analysis after 2, 6 and 12 weeks. Proteolysis was assessed by urea-polyacrylamide gel electrophoresis, which showed that cheeses manufactured with the Munida extracts had a higher extent of degradation of beta-casein than cheeses made using chymosin as coagulant. Patterns of proteolysis were also obtained by reverse-phase high-performance liquid chromatography (RP-HPLC) and matrix assisted laser desorption ionisation-time of flight (MALDI-ToF) mass spectrometry. In general, the products of proteolysis were more complex in cheese made using the Munida extracts than in cheese made by chymosin as coagulant. Statistical analysis of results clearly discriminated the cheeses on the basis of coagulant used. Molecular mass of peptides found in cheese made using Munida extracts were similar to those of peptides commonly detected in cheeses made using chymosin as coagulant.


Sujet(s)
Fromage/analyse , Technologie alimentaire , Animaux , Biotechnologie , Caséines/isolement et purification , Chromatographie en phase liquide à haute performance , Chymosine , Coagulants , Crustacea/enzymologie , Électrophorèse sur gel de polyacrylamide , Peptide hydrolases , Spectrométrie de masse MALDI
11.
Eur Biophys J ; 34(8): 1041-8, 2005 Nov.
Article de Anglais | MEDLINE | ID: mdl-15917983

RÉSUMÉ

We report an X-ray reflectivity study on the effects of adsorption of myelin basic protein (MBP) on Langmuir monolayers and on deposited Langmuir-Schaefer multilayers of the phospholipid dipalmitoyl phosphatidylglycerol (DPPG). We provide for the first time, direct microscopic evidence on the destructuring effects of MBP leading to plasticity of the DPPG layers supporting commonly accepted models of the stabilizing role of MBP in the myelin membrane. We also show how protein adsorption onto the layer is determined both by electrostatic and nonspecific hydrophobic interactions.


Sujet(s)
Double couche lipidique/composition chimique , Fluidité membranaire , Protéines membranaires/composition chimique , Modèles chimiques , Modèles moléculaires , Protéine basique de la myéline/composition chimique , Phospholipides/composition chimique , Adsorption , Simulation numérique , Conformation moléculaire , Transition de phase , Liaison aux protéines
12.
J Biol Regul Homeost Agents ; 18(1): 9-17, 2004.
Article de Anglais | MEDLINE | ID: mdl-15323355

RÉSUMÉ

Extra corporeal photochemotherapy (ECP) is an immunomodulating procedure used in several nonneurological diseases which, similarly to multiple sclerosis, are likely to be due to T-cell-mediated autoimmunity and it is probable that ECP can modulate the normal activity of peripheral blood mononuclear cells (PBMC). Using the Lewis rat experimental allergic encephalomyelitis (EAE) model of human multiple sclerosis (MS) we examined the effect of extracorporeal UV-A irradiation on psoralen-activated PBMC. In our experiment the comparison between the two groups of animals (ECP or sham-treatment) evidenced that the ECP treatment reduced the severity of EAE on clinical grounds and this result was confirmed by the pathological examination. The changes in the titers of anti-myelin antigen antibodies typical of EAE were also modulated by the procedure. Ex vivo examination evidenced a significant reduction in tumor-necrosis factor-alpha (TNF-alpha) released by PBMC after lipopolysaccharides (LPS) stimulation in culture. We conclude that ECP modifies the normal activity of PBMC during the course of EAE and it is possible that one of the anti-inflammatory mechanisms of action of ECP is correlated to a down-regulation of T-helper 1 lymphocytes activity.


Sujet(s)
Encéphalomyélite auto-immune expérimentale/immunologie , Agranulocytes/immunologie , Animaux , Corticostérone/métabolisme , Cytokines/métabolisme , Régulation négative , Encéphalomyélite auto-immune expérimentale/thérapie , Femelle , Humains , Lumière , Lipopolysaccharides/métabolisme , Sclérose en plaques/immunologie , Protéine basique de la myéline/métabolisme , Photothérapie dynamique , Rats , Rats de lignée LEW , Facteurs temps , Facteur de nécrose tumorale alpha/métabolisme , Rayons ultraviolets
13.
J Neuroimmunol ; 151(1-2): 55-65, 2004 Jun.
Article de Anglais | MEDLINE | ID: mdl-15145604

RÉSUMÉ

Pixantrone is less cardiotoxic and is similarly effective to mitoxantrone (MTX) as an antineoplastic drug. In our study, pixantrone reduced the severity of acute and decreased the relapse rate of chronic relapsing experimental allergic encephalomyelitis (EAE) in rats. A marked and long-lasting decrease in CD3+, CD4+, CD8+ and CD45RA+ blood cells and reduced anti-MBP titers were observed with both pixantrone and MTX. In vitro mitogen- and antigen-induced T-cell proliferation tests of human and rodents cells evidenced that pixantrone was effective at concentrations which can be effectively obtained after i.v. administration in humans. Cardiotoxicity was present only in MTX-treated rats. The effectiveness and the favorable safety profile makes pixantrone a most promising immunosuppressant agent for clinical use in multiple sclerosis (MS).


Sujet(s)
Encéphalomyélite auto-immune expérimentale/traitement médicamenteux , Immunosuppresseurs/usage thérapeutique , Isoquinoléines/usage thérapeutique , Lymphocytes T/effets des médicaments et des substances chimiques , Maladie aigüe , Animaux , Division cellulaire/effets des médicaments et des substances chimiques , Cellules cultivées , Maladie chronique , Femelle , Humains , Immunosuppresseurs/effets indésirables , Isoquinoléines/effets indésirables , Numération des lymphocytes , Mitoxantrone/effets indésirables , Mitoxantrone/usage thérapeutique , Rats , Lymphocytes T/immunologie
14.
Biophys J ; 86(1 Pt 1): 455-60, 2004 Jan.
Article de Anglais | MEDLINE | ID: mdl-14695288

RÉSUMÉ

The structure of myelin basic protein (MBP), purified from the myelin sheath in both lipid-free (LF-MBP) and lipid-bound (LB-MBP) forms, was investigated in solution by small angle x-ray scattering. The water-soluble LF-MBP, extracted at pH < 3.0 from defatted brain, is the classical preparation of MBP, commonly regarded as an intrinsically unfolded protein. LB-MBP is a lipoprotein-detergent complex extracted from myelin with its native lipidic environment at pH > 7.0. Under all conditions, the scattering from the two protein forms was different, indicating different molecular shapes. For the LB-MBP, well-defined scattering curves were obtained, suggesting that the protein had a unique, compact (but not globular) structure. Furthermore, these data were compatible with earlier results from molecular modeling calculations on the MBP structure which have been refined by us. In contrast, the LF-MBP data were in accordance with the expected open-coil conformation. The results represent the first direct structural information from x-ray scattering measurements on MBP in its native lipidic environment in solution.


Sujet(s)
Lipides/composition chimique , Modèles moléculaires , Protéine basique de la myéline/composition chimique , Diffraction des rayons X/méthodes , Simulation numérique , Lipides/analyse , Protéine basique de la myéline/analyse , Protéine basique de la myéline/classification , Liaison aux protéines , Diffusion de rayonnements , Solutions
15.
Brain ; 127(Pt 2): 398-407, 2004 Feb.
Article de Anglais | MEDLINE | ID: mdl-14662518

RÉSUMÉ

The introduction of potent antiretroviral drugs for the treatment of patients with human immunodeficiency virus (HIV) infection has dramatically reduced the prevalence of HIV-associated neurological disorders. Such diseases can be mediated by proteolytic enzymes, i.e. matrix metalloproteinases (MMPs) and, in particular gelatinases, released from glial cells. The aim of this study was to investigate whether the antiretroviral drugs commonly used for the treatment of HIV-infected patients modulate the activity of MMPs in astrocyte and microglial cultures. Primary cultures of rat astrocyte and microglia were treated with different doses of zidovudine (AZT) or indinavir (IDV) for 20 h and simultaneously activated by exposure to lipopolysaccharide (LPS). Culture supernatants collected from astrocytes and microglia after 24 h incubation were subjected to gelatin zymography and western blot analysis for the assessment of MMP-2 (gelatinase A) and MMP-9 (gelatinase B) protein levels. Total RNA was extracted from glial cells and used for reverse transcriptase-polymerase chain reaction for the assessment of mRNA expression. Our results indicate that both astrocyte and microglial cells constitutively express MMP-2 mRNA and protein. LPS treatment increased MMP-2 mRNA and protein expression in astrocytes, but not in microglial cells. The treatment with both AZT and IDV dose-dependently inhibited the expression of MMP-2 in astrocytes, whereas it had no effect on microglial cells. The expression of MMP-9 in both astrocytes and microglia was induced by LPS treatment and was dose-dependently inhibited by AZT and IDV treatment in LPS-stimulated astrocytes and microglia. These results raise the possibility that AZT and IDV interfere directly with MMP production in glial cells and independently from their antiviral activity, thus suggesting the possible therapeutical use in neurological diseases associated with MMPs involvement.


Sujet(s)
Agents antiVIH/pharmacologie , Astrocytes/effets des médicaments et des substances chimiques , Inhibiteurs de métalloprotéinases matricielles , Microglie/effets des médicaments et des substances chimiques , Animaux , Astrocytes/enzymologie , Cellules cultivées , Relation dose-effet des médicaments , Antienzymes/pharmacologie , Régulation de l'expression des gènes codant pour des enzymes/effets des médicaments et des substances chimiques , Indinavir/pharmacologie , Lipopolysaccharides/pharmacologie , Matrix metalloproteinase 2/génétique , Matrix metalloproteinase 2/métabolisme , Matrix metalloproteinase 9/génétique , Matrix metalloproteinase 9/métabolisme , Matrix metalloproteinases/métabolisme , Microglie/enzymologie , ARN messager/génétique , Rats , RT-PCR , Zidovudine/pharmacologie
16.
Brain Res Bull ; 61(3): 357-64, 2003 Aug 15.
Article de Anglais | MEDLINE | ID: mdl-12909305

RÉSUMÉ

In Multiple Sclerosis (MS) pathology, early inflammation involves leukocyte migration across the blood-brain barrier (BBB) within the central nervous system. In this process, adhesion molecules (AMs), both membrane-bound and soluble-circulating forms, and matrix metalloproteinases (MMPs) certainly play a regulatory role. In MS, recombinant Interferon-beta (rIFNbeta) is effective in reducing gadolinium contrast-enhancing lesions on magnetic resonance imaging and this suggests that it may reduce BBB damage or even restore its integrity by different mechanisms that include interference with both AM and MMP pathways. This review will highlight the effects induced by rIFNbeta, both in vitro and in vivo, on cell-bound and soluble forms of AMs and on MMPs.


Sujet(s)
Molécules d'adhérence cellulaire/immunologie , Interféron bêta/immunologie , Roulement des leucocytes/immunologie , Matrix metalloproteinases/immunologie , Sclérose en plaques/immunologie , Animaux , Barrière hémato-encéphalique/immunologie , Molécules d'adhérence cellulaire/métabolisme , Humains , Interféron bêta/métabolisme , Interféron bêta/pharmacologie , Matrix metalloproteinases/métabolisme , Sclérose en plaques/métabolisme , Protéines recombinantes
17.
J Biotechnol ; 101(3): 289-93, 2003 Mar 20.
Article de Anglais | MEDLINE | ID: mdl-12615397

RÉSUMÉ

R-Phycoerythrin (R-PE) is a protein acting as a photosynthetic accessory pigment in red algae (Rodophyta). This protein has gained importance in many biotechnological applications in food science, immunodiagnostic, therapy, cosmetics, protein and cell labelling, and analytical processes. In this paper we report on a new, one step procedure for the extraction and purification of R-PE from a new source: the Mediterranean red algae Corallina elongata Ellis & Solander. This red algae contains mainly R-PE and is suitable for the production in culture. No other contaminating phycobiliproteins could be detected in the extracts. The method we propose for the purification is based on the use of hydroxyapatite, a chromatographic resin that can be produced in the laboratory at very low cost and can be used batch-wise with large amounts of extracts, alternative to chromatography, and therefore can be scaled up. Both the yield and the purity of R-PE are very good.


Sujet(s)
Chromatographie/méthodes , Durapatite , Phycoérythrine/biosynthèse , Phycoérythrine/isolement et purification , Rhodophyta/métabolisme , Adsorption , Mer Méditerranée , Phycoérythrine/composition chimique , Phycoérythrine/classification , Rhodophyta/composition chimique , Spécificité d'espèce
18.
Biophys J ; 83(6): 3507-12, 2002 Dec.
Article de Anglais | MEDLINE | ID: mdl-12496117

RÉSUMÉ

For the first time x-ray absorption spectroscopy was used to investigate the Zn environment in Langmuir-Blodgett multilayers. The multilayers were taken as a model of the multilamellar structure of the myelin sheath, the membrane surrounding the nerve axon, which plays a crucial role for signal transduction along the axon. The layers were assembled from the phospholipid dilauroylphosphatidic acid, both in the presence and in the absence of myelin basic protein. The analysis of the extended x-ray absorption fine structure and of the near edge regions of the x-ray absorption spectra at the Zn K-edge provided an accurate description of the local structure showing that the Zn ions are bound to the heads of the phospholipid molecules. The myelin basic protein induces a distortion on the Zn local environment due to a steric constraint but does not substitute the phosphate headgroups. These findings represent an important step in understanding the interplay among myelin basic protein, Zn, and the lipids of the myelin sheath.


Sujet(s)
Absorptiométrie photonique/méthodes , Lipides membranaires/composition chimique , Protéine basique de la myéline/composition chimique , Acides phosphatidiques/composition chimique , Zinc/composition chimique , Sites de fixation , Double couche lipidique/composition chimique , Structures macromoléculaires , Protéines membranaires/composition chimique , Membrane artificielle , Conformation moléculaire , Gaine de myéline/composition chimique , Phospholipides/composition chimique , Conformation des protéines
19.
Mult Scler ; 8(3): 222-8, 2002 May.
Article de Anglais | MEDLINE | ID: mdl-12120694

RÉSUMÉ

Matrix metalloproteinase-9 (MMP-9) was detected by zymography and enzyme-linked immunosorbent assay (ELISA) in matched serum and cerebrospinal fluid (CSF) samples from patients with neurological diseases. Patients with relapsing-remitting multiple sclerosis (RR-MS) had serum and CSF MMP-9 levels comparable to those from patients with inflammatory neurological diseases (INDs), but higher than patients with non-inflammatory neurological diseases (NINDs) and healthy donors (HDs). MMP-9 increased in active RR-MS in comparison with inactive RR-MS implying that MMP-9 in MS is related with clinical disease activity. A correlation between the CSF/serum albumin (Q(AIb)) and CSF/serum MMP-9 (Q(MMP-9)) was observed in IND and NIND but not in RR-MS patients, indicating that CSF MMP-9 levels in NIND and IND patents could be influenced by serum MMP-9 and blood-brain barrier (BBB) permeability properties. MS patients had higher values of Q(MMP-9):Q(Alb)(MMP-9 index) than IND and NIND patients suggesting that in MS the increase in CSF MMP-9 could be due to intrathecal synthesis of MMP-9. A significant inverse correlation was found between MMP-9 and its endogenous inhibitor TIMP-1 in RR-MS indicating that in MS patients both the increase in MMP-9 and the decrease in TIMP-1 serum levels could contribute to BBB disruption and T-lymphocyte entry into the CNS.


Sujet(s)
Matrix metalloproteinase 9/liquide cérébrospinal , Sclérose en plaques récurrente-rémittente/liquide cérébrospinal , Sclérose en plaques récurrente-rémittente/étiologie , Adulte , Barrière hémato-encéphalique , Femelle , Humains , Mâle , Matrix metalloproteinase 2/sang , Matrix metalloproteinase 2/liquide cérébrospinal , Matrix metalloproteinase 9/sang , Adulte d'âge moyen , Sclérose en plaques récurrente-rémittente/sang , Inhibiteur tissulaire de métalloprotéinase-1/sang , Inhibiteur tissulaire de métalloprotéinase-1/liquide cérébrospinal
20.
Eur J Immunol ; 31(9): 2762-70, 2001 Sep.
Article de Anglais | MEDLINE | ID: mdl-11536175

RÉSUMÉ

We present the first evidence of a T lymphocyte response to N-formylated peptides in humans. N-formylated peptide sequences from self (mitochondrial) and foreign (microbial) antigens were used to isolate antigen-specific T cell clones from healthy individuals, including a set of monozygotic twins. The observed response differed from that previously described in mouse (CD4(+) phenotype and MHC class II restriction in humans vs. CD8(+) phenotype and class I restriction in mice). These lymphocytes produce substantial amounts of IFN-gamma. They were isolated in only one of the monozygotic twins, which suggests that their expansion in the healthy immune repertoire is independent of the genetic background. Our result will help in assessing the relevance of N-formylated peptide-specific T cells in protection against infections within the human immune system.


Sujet(s)
Lymphocytes T CD4+/immunologie , N-Formyl-méthionine/immunologie , Peptides/immunologie , Adulte , Séquence d'acides aminés , Présentation d'antigène , Cellules cultivées , Clones cellulaires , Femelle , Antigènes d'histocompatibilité de classe II/immunologie , Humains , Immunophénotypage , Interféron gamma/biosynthèse , Interleukine-4/biosynthèse , Activation des lymphocytes , Mâle , Adulte d'âge moyen , Peptides/synthèse chimique , Peptides/composition chimique , Récepteurs aux antigènes des cellules T/génétique , Sous-populations de lymphocytes T/classification
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE